Drug Cost Standards Task Force - Developing Standards for Drug Costs in Pharmacoeconomic Studies Co-Chairs: Joel W Hay PhD, Jim Smeeding RPh, MBA Good Research Practices for the Application of Conjoint Analysis in Health Task Force Chair: John F. P. Bridges PhD
PRO Task Force: Use Of Existing Instruments and Their Modification Chair: Margaret Rothman PhD
ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Chair: William McGhan PharmD, PhD Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report Citation: McGhan WF, Al M, Doshi JA, et al. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. Value Health 2009;12.
Good Research Practices for Retrospective Database Analysis Task Force Chair: Michael Johnson PhD, Associate Professor University of Houston, College of Pharmacy, Houston, TX, USA
ISPOR Good Practices Task Force on Transferability of Economic Data Chair: Michael Drummond PhD Transferability Of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report Citation: Drummond, M, Barbieri, M, Cook, J, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health 2009; 12:4:409-418.
ISPOR PRO Task Force: Changing Culture or Language of an Application Chair: Diane Wild Multinational Trials—Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: The ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force Report Citation: Wild D, Eremenco S, Mear I, et al. Multinational trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data: the ISPOR Patient Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Value Health 2009;12:430-440.
ISPOR EPRO Good Research Practices Task Force Chair: Stephen Joel Coons Recommendations on Evidence Needed to Support Measurement Equivalence Between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR EPRO Good Research Practices Task Force Report Citation: Coons SJ, Gwaltney C, Hays R, Lundy J, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-report outcome (PRO) measures: ISPOR EPRO Good Research Practices Task Force report. Value Health 2009; 12:4:419-429
Building a Pragmatic Road Forward: An ISPOR Consensus Development Workshop on the Future of the QALY
ISPOR Medication And Compliance Special Interest Group Understanding Medication Compliance and Persistence from an Economics Perspective Citation: Elliot R, Shinogle J, Peele P, Bhosle M, et al. Understanding medication compliance and persistence from an economics perspective. Value Health 2008; 11:4:600-610
ISPOR Task Force On Good Research Practices – Budget Impact Analysis Chair: Josephine Mauskopf Principles Of Good Practice For Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis) Citation: Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value Health 2007; 10; 336-47 ISPOR Medication Compliance and Persistence Special Interest Group (MCP)
ISPOR Task Force for Translation and Cultural Adaptation Chair: Diane Wild Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation Citation: Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translating adaptation. Value Health 2005; 2:94-104.
ISPOR Code of Ethics Task Force Chair: Francis Palumbo ISPOR Code of Ethics for Researchers Background Article - Report of the ISPOR Task Force on Code of Ethics for Researchers Citation: Palumbo F, Barnes R, Deverka, M, McGhan W, Mullany L, Wertheimer A. ISPOR Code of Ethics for Researchers Background Article - Report of the ISPOR Task Force on Code of Ethics for Researchers. Value Health 2004; 7:111-117
ISPOR Randomized Clinical Trial Cost-Effectiveness Task Force Chairs: Scott Ramsey and Richard Willke Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report Citation: Ramsey, Scott, Willke, Richard, Briggs, Andrew, Brown, Ruth, Buxton, Martin, Chawla, Anita, Cook, John, Glick, Henry, Liljas, Bengt, Petitti, Diana & Reed, Shelby (2005) Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report. Value Health 2005; 8: 521-533.
ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health Care Decision-Making Chair: Michael Drummond Report of The ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health Care Decision-Making Citation: Drummond M, Brown R, Fendrick AM, et al. Use of pharmacoeconomics information-Report of the ISPOR task force on use of pharmacoeconomic/health economic information in health-care decision-making. Value Health 2003; 6:40 7-16. ISPOR Medication and Compliance Special Interest Group Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes Citation: Cramer J, Rosenheck R, Kirk G, et al. Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes. Value Health 2003; 6:5:66-73.
ISPOR Task Force on Retrospective Databases Chair: Brenda Motheral A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases Citation: Motheral B, Brooks J, Clark MA, et al. A checklist for retroactive database studies -Report of the ISPOR Task Force on Retrospective Databases. Value Health 2003; 6:90-7
ISPOR Task Force On Good Research Practices-Modeling Studies Chair: Milt Weinstein Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies Citation: Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice of decision analytic modeling in health care evaluation: Report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health2003; 6:9-17
ISPOR Advisory Panel Meeting and Conference on Pharmacoeconomic Issues ISPOR Advisory Panel Meeting and Conference on Pharmacoeconomic Issues Report
For more information on ISPOR health science initiatives, see ISPOR Health Science Policy Council and the ISPOR Special Interest Group initiatives (http://www.ispor.org/sigs/sigsindex.asp)
Contact ISPOR @ info@ispor.org | View Legal Disclaimer ©2010 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. Website design by Eagle Systems USA, Inc.
